Klin Monbl Augenheilkd 2025; 242(08): 807-812
DOI: 10.1055/a-2650-7436
Übersicht

Cataract Surgery and DMEK: Decision-making and the Timing of the Respective Interventions

Article in several languages: English | deutsch
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
,
Maximilian Friedrich
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
,
Hyeck-Soo Son
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
,
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
,
Gerd U. Auffarth
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
,
1   Klinik für Augenheilkunde, David J. Apple International Laboratory for Ocular Pathology und International Vision Correction Research Centre (IVCRC), Ruprecht-Karls-Universität Heidelberg, Germany
2   Klinik für Augenheilkunde, Universitätsklinikum Carl Gustav Carus Dresden, Germany
› Author Affiliations
Preview

Abstract

With the introduction of Descemet membrane endothelial keratoplasty (DMEK), the treatment of endothelial corneal diseases such as Fuchsʼ corneal endothelial dystrophy (FECD) has been significantly optimised. Thanks to rapid and good visual rehabilitation, surgery is advised in earlier stages of the disease. When patients are 50 – 70 years old, not only the FECD, but also cataract can become increasingly functionally relevant. It is therefore important to accurately assess and quantify the functional limitations of both conditions, in order to determine which surgery (DMEK and/or cataract surgery) is more useful and imminent. One possibility is to perform a so-called triple DMEK (DMEK combined with cataract surgery). This is an option for phakic patients who are no longer able to accommodate and have clinical or subclinical, tomographic corneal oedema, as this would avoid early DMEK subsequent to cataract surgery. However, if cataract patients with FECD do not exhibit any relevant (clinical or subclinical) corneal oedema, they may benefit from cataract surgery alone without DMEK. Nevertheless, visual quality may remain limited by the corneal guttae and DMEK may still be necessary later. The third option is to perform DMEK without cataract surgery in phakic patients. This may be considered in young FECD patients without cataract who are still accommodating FECD. However, it is important to note that when cataract surgery is required later, the endothelial cell loss resulting from cataract surgery may lead to earlier DMEK graft failure. Overall, in patients with FECD and an age-related lens opacification or incipient cataract, the need and timing of the respective intervention must be determined individually, in order to achieve the optimal therapeutic success. The procedure described in this manuscript can help support decision-making and the timing of the respective interventions.



Publication History

Received: 17 February 2025

Accepted: 23 June 2025

Article published online:
21 August 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany